The CYP2R1 gene helps the liver change vitamin D from sunlight, food, and supplements into the main form measured in blood. This gene plays an important role in keeping vitamin D available for healthy bones and muscles. If it does not work well, you may develop low vitamin D levels, soft or weak bones, bone pain, muscle weakness, or rickets in childhood. CYP2R1 is mainly known in clinical genetics rather than popular culture.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions for making molecules or managing processes in the body. Some genes hold the code for proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they operate. Together, genes help direct how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can read more in the LearnHub.
Overview
CYP2R1Gene function
What if the gene works
The CYP2R1 gene helps your liver turn vitamin D from food and sunlight into the main form measured in blood. This supports calcium balance and healthy bones.
Risk
What if the gene does not work
Variants in the CYP2R1 gene can reduce the body’s first step in activating vitamin D. More disruptive variants may cause vitamin D-dependent rickets, with soft or weak bones, poor growth, and symptoms that can range from mild to more marked.
Treatment
What does that mean for your treatment
Pathogenic variants in the CYP2R1 gene can make standard vitamin D3 or D2 less effective, so treatment often shifts to calcifediol or an active vitamin D medicine such as calcitriol, which bypasses the blocked step. Care is then adjusted using blood levels of calcium, phosphate, parathyroid hormone, and 25 hydroxyvitamin D.
Conditions associated with CYP2R1
Gene function
What if the gene works
Your body uses the CYP2R1 gene during one of the earliest steps of vitamin D handling. In the liver, it helps turn vitamin D from sunlight, food, or supplements into a form that can travel in the blood and be used later. This steady job supports normal vitamin D balance.
The CYP2R1 gene provides instructions for a key liver enzyme that changes vitamin D into 25-hydroxyvitamin D (the main form of vitamin D in blood). This is a central part of vitamin D activation in the liver.
This processing step creates the vitamin D form your body keeps available for later use. It is also the form most often measured in a vitamin D blood test.
Its enzyme can work on both vitamin D2 and vitamin D3. This helps your body handle vitamin D from food, supplements, and vitamin D made in the skin after sunlight exposure.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP2R1 gene can reduce or block the enzyme's ability to convert vitamin D into 25-hydroxyvitamin D, the main form measured in blood. Some changes slightly lower enzyme activity or stability, while more severe variants can leave little or no working enzyme. This spectrum means CYP2R1 gene variants can affect vitamin D activation to different degrees and may be linked to earlier or more noticeable bone changes in vitamin D–dependent rickets type 1B.
How variants are linked to conditions
Pathogenic variants in the CYP2R1 gene can cause vitamin D dependent rickets type 1B, a rare inherited condition with low vitamin D levels, soft bones, poor growth, and delayed walking. In larger population studies, other variants in the CYP2R1 gene are linked to lower vitamin D levels and may modestly affect bone health. These common findings describe risk, not a certain diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Changes in the CYP2R1 gene can make low vitamin D levels more likely, and this may be more noticeable with little sun exposure, low vitamin D intake, obesity, or conditions that affect how the body absorbs food. The genetic change itself is the main driver, so lifestyle steps may help vitamin D levels but do not remove the underlying genetic tendency.
Inheritance of CYP2R1 variants
For families asking how CYP2R1 gene variants are inherited, the well-established pattern is autosomal recessive. This means a person usually develops CYP2R1-related vitamin D hydroxylation deficiency when they inherit two nonworking copies of the CYP2R1 gene, one from each parent. Parents who each carry one variant are often unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither familial variant. Sons and daughters are affected at the same rate.
What does my CYP2R1 result mean for my family?
For CYP2R1, family implications are usually discussed in the setting of a rare inherited condition that affects vitamin D processing and can lead to rickets or soft bones. This condition is typically passed down in a recessive way, so parents, brothers, sisters, and children may want to know whether they carry the same gene change. Close relatives are often healthy carriers, while some family members with two changed copies may have bone symptoms or low vitamin D-related problems.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the CYP2R1 gene can help explain inherited low vitamin D levels. CYP2R1 genetic testing for vitamin D deficiency usually uses a blood or saliva sample, and the lab reads the DNA code to look for variants that may confirm a genetic cause or support a diagnosis.
When should I consider getting a genetic test?
Consider CYP2R1 genetic testing if you or your child has very low vitamin D levels with soft, weak, or painful bones, bowing of the legs, or poor growth, especially when this runs in the family or standard vitamin D treatment has not helped as expected. Testing can confirm a rare inherited vitamin D–related bone condition.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies based on the condition and the type of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, or uses a drug. These differences are common and are one of several factors, along with age, other health conditions, and other medicines, that shape treatment response.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences affect the way people respond to medications. It examines relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed, more individualized treatment decisions. To explore this topic further, you can learn more in LearnHub.
Drugs influenced by the CYP2R1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medications, so general medication concerns are best discussed with your doctor. For CYP2R1, research has mainly looked at vitamin D levels and how some people respond to vitamin D supplements, but this is not used routinely to guide treatment.
History
For many years, doctors knew the body had to process vitamin D in steps, but the exact genes involved were not fully clear. In the early 2000s, researchers identified the CYP2R1 gene as a major part of this pathway, which marked an important step in vitamin D research. From these first observations, research expanded steadily. Scientists then linked rare variants in the CYP2R1 gene to an inherited form of vitamin D–related rickets, showing that changes in this gene could have clear clinical effects. Later studies also found that more common variants in the CYP2R1 gene can influence vitamin D levels in the wider population, helping connect laboratory research with everyday health.